Eli Lilly and Company

Pharma / Pharma

Info

Overview Core Facts Blog Ratings Executives

Analytics

Company Q&A Industry Q&A Competitors Stock Swings SWOT PEST Porter's Five Forces Score Positive Risks Revenue Segmentation

Financials

Income Statement Balance Sheet Cash Flow Statement

Ratios

Financial Ratios Financial Growth Enterprise Value Key Metrics Dividends

Tools

Due Diligence

Resources

News Clusters SEC Filings Stock Split History Press Releases Insider Trades Owner Earnings Earnings Calendar Web Reports

Cash Flow Statement

Pay attention and research significant changes from year to year values. [ ! ]

Fixed Column	Net Income	Depreciation And Amortization	Deferred Income Tax	Stock Based Compensation	Change In Working Capital	Accounts Receivables	Inventory	Accounts Payables	Other Working Capital	Other Non Cash Items	Net Cash Provided By Operating Activities	Investments In Property Plant And Equipment	Acquisitions Net	Purchases Of Investments	Sales Maturities Of Investments	Other Investing Activities	Net Cash Used For Investing Activities	Debt Repayment	Common Stock Repurchased	Dividends Paid	Other Financing Activities	Net Cash Used Provided By Financing Activities	Effect Of Forex Changes On Cash	Net Change In Cash	Cash At End Of Period	Cash At Beginning Of Period	Operating Cash Flow	Capital Expenditure
2024-12	10590.0	0.0	-2683.1	645.6	0.0	0.0	0.0	0.0	0.0	265.39	8817.9	-5057.8	-947.7	-775.8	522.5	-3042.7	-9301.5	8901.1	-2500.0	-4680.39	-490.6	1230.09	-296.7	449.8	3268.4	2818.6	8817.9	-8403.6
2023-12	5240.39	1527.3	-2341.0	628.5	-3055.0	-2451.0	-1425.0	4274.39	-3453.4	2239.9	4240.1	-3447.6	-1044.3	-829.0	700.3	-2532.1	-7152.7	8649.9	-750.0	-4069.3	-335.0	3495.6	168.6	751.6	2818.6	2067.0	4240.1	-7392.1
2022-12	6244.8	1522.5	-2185.19	371.1	-14.5	-299.6	-599.7	1331.7	-446.9	1145.7	7084.4	-2484.0	-327.2	-707.6	463.6	-206.4	-3261.6	-62.0	-1500.0	-3535.8	-308.89	-5406.7	-167.6	-1751.5	2067.0	3818.5	7084.4	-2484.0
2021-12	5581.7	1547.6	-802.3	342.8	-1022.6	-1278.3	-235.9	-664.1	1155.7	1613.5	7260.7	-1873.2	-747.4	-1013.4	847.4	24.3	-2762.3	501.4	-1250.0	-3086.8	-295.89	-4131.3	-205.7	161.4	3818.5	3657.1	7260.7	-1873.2

Explore more cash flow data for Eli Lilly and Company!

What is special about us?

Imprint

Disclaimer

×
Disclaimer

InsightfulValue is an independent platform dedicated to value investing research. The information provided on this website is for informational and educational purposes only and does not constitute financial, investment, tax, or legal advice.
We are not financial advisors, investment consultants, or licensed consultants. Our analyses, insights, and criteria are based on principles learned from renowned value investors such as Benjamin Graham, Warren Buffett, and Charlie Munger, but they should not be considered personalized investment recommendations.
Investing in financial markets carries risks, and past performance is not indicative of future results. Users of this website should conduct their own due diligence and consult with a qualified professional before making any financial or investment decisions. InsightfulValue assumes no liability for any financial losses or decisions made based on the information provided on this site.
By using this website, you acknowledge and accept that all investments involve risk and that InsightfulValue does not guarantee any financial outcomes.

Legal

Due Diligence

This feature is only available for users with Insider or Visionary license. Please, signup or login.